Spike 1 protein of SARS-CoV-2 induces endothelial inflammation and vascular dysfunction through interferon ISG15-dependent mechanisms
Cardiovascular Research · 11.07.2026 · 122 (10) · 1344-1358
DOI: 10.1093/cvr/cvag111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 18.05.2026. Verfasst von Francisco J Rios und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Research Institute of the McGill University Health Centre, 1001, boul Décarie, ES1.5066.6, Montreal, Québec H4A 3J1, Canada. Hauptthemen laut MEDLINE: Cytokines, SARS-CoV-2, Ubiquitins, Endothelial Cells. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, AEI, MICIU.
Abstract (Originalsprache)
Aims
Interferon (IFN) alpha (IFNα) and lambda3 (IFNλ3) constitute first-line responses of immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by increasing interferon-stimulated genes (ISGs). Prolonged IFN production may exacerbate inflammation, contributing to endotheliitis and vascular dysfunction in coronavirus disease 2019 (COVID-19). We investigated whether spike protein S1 (SP1) of SARS-CoV-2 via IFN influences inflammation in human vascular and lymphatic endothelial cells (ECs) and whether these processes contribute to vascular dysfunction in the context of hypertension. We focused on ISG15, a crucial immune protein that is also implicated in hypertension-associated vascular injury. Methods and results Exposure of microvascular ECs to SP1 of SARS-CoV-2-induced expression of ISGs: ISG15, MX1, and IFIT1. These effects were potentiated by IFNs and reduced by ADAM17 and STAT1 inhibition and genetic inhibition of IFNα and beta receptor subunit 1 (IFNAR1). In microvascular ECs IFNλ3 and IFNα increased expression of ISGs, TMPRSS2, ADAM17, production of pro-inflammatory mediators (tumor necrosis factor [TNF]α, interleukin [IL]-6, plasminogen activator inhibitor [PAI]-1) and reduced phosphorylation of eNOS (Ser1177). In pulmonary, lymphatic, and aortic ECs, IFNα, but not IFNλ3, increased expression of ISGs and IL-6. To explore the relevance in intact vessels, effects of IFNs were studied in isolated micro-vessels from wildtype (WT), hypertensive and ISG15−/− mice. IFNα, IFNλ3, and SP1 reduced endothelium-dependent relaxation in WT vessels, whereas IFNα increased contraction in vessels from hypertensive mice. Vascular dysfunction induced by IFNα, IFNλ3 or spike protein was abrogated in vessels from ISG15−/− mice.
Conclusion
SP1 and IFNs synergically increase EC expression of ISGs through ADAM17. IFNλ3 and IFNα promote endothelial inflammation and vascular dysfunction through ISG15. These processes may play a role in the endotheliopathy and vascular damage associated with SP1 and might contribute to cardiovascular sequelae, including hypertension, of SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Research Institute of the McGill University Health Centre, 1001, boul Décarie, ES1.5066.6, Montreal, Québec H4A 3J1, Canada.
- School of Medicine, Pharmacy and Biomedical Sciences, University of Portsmouth, St Michael's building, White Swan Rd, Portsmouth PO1 2DT, UK.
- Institute of Cardiovascular and Medical Sciences, British Heart Foundation (BHF), Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
- Departmento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Physiology, Universidad Autónoma de Madrid, Instituto Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain.
ORCID-Profile: Ana M Briones, John McLauchlan, Rhian M Touyz
Förderung
- Wellcome Trust
- AEI
- MICIU
- Canada Research Chair
- McGill University
- CIHR
- British Heart Foundation
- Canadian Institutes of Health Research
Zitieren
APA
Rios, F. J., Montezano, A. C., Camargo, L. L., Lopes, R. A., García-Redondo, A. B., Aranday-Cortes, E., Briones, A. M., McLauchlan, J., & Touyz, R. M. (2026). Spike 1 protein of SARS-CoV-2 induces endothelial inflammation and vascular dysfunction through interferon ISG15-dependent mechanisms. Cardiovascular Research, 122(10), 1344-1358. https://doi.org/10.1093/cvr/cvag111
Vancouver
Rios FJ, Montezano AC, Camargo LL, Lopes RA, García-Redondo AB, Aranday-Cortes E, et al. Spike 1 protein of SARS-CoV-2 induces endothelial inflammation and vascular dysfunction through interferon ISG15-dependent mechanisms. Cardiovascular Research. 2026;122(10):1344-1358. doi:10.1093/cvr/cvag111
BibTeX
@article{Rios2026,
author = {Rios, Francisco J and Montezano, Augusto C and Camargo, Livia L and Lopes, Rheure A and García-Redondo, Ana B and Aranday-Cortes, Elihu and Briones, Ana M and McLauchlan, John and Touyz, Rhian M},
title = {Spike 1 protein of SARS-CoV-2 induces endothelial inflammation and vascular dysfunction through interferon ISG15-dependent mechanisms},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {10},
pages = {1344--1358},
doi = {10.1093/cvr/cvag111}
}
EUVIMED